former aimmune therapeutics ceo: taking stock in allergies | mad money
Published 6 years ago • 2.9K plays • Length 5:55Download video MP4
Download video MP3
Similar videos
-
4:21
watch cnbc's interview with aimmune therapeutics ceo on the company's peanut therapy
-
6:14
intarcia therapeutics ceo: holy grail of disease treatment | mad money | cnbc
-
6:04
karyopharm therapeutics ceo: combatting cancer | mad money | cnbc
-
6:06
cara therapeutics ceo: battling opioids | mad money | cnbc
-
5:25
nestle ceo on the company's aimmune therapeutics acquisition
-
6:26
sangamo therapeutics ceo: alzheimer's and parkinson's gene therapies | mad money | cnbc
-
4:38
food allergies an immense opportunity, nestle health science chief says
-
5:52
seres therapeutics ceo: changing the bacterial ecosystem | mad money | cnbc
-
28:59
is lithium the answer to a regulated nervous system, depression & addiction treatment?
-
5:19
cramer: this biotech stock could be worth over $100 billion on an fda approval
-
4:10
alexander seyf - co founder & ceo of autolomous talks to ibtv at meeting on the mesa in phoenix.
-
6:08
cellectis ceo: creating a cancer fighting machine | mad money | cnbc
-
6:39
halozyme therapeutics ceo dr. helen torley | mad money | cnbc
-
6:43
therapeuticsmd ceo: strides for women’s health | mad money | cnbc
-
7:16
therapeuticsmd chairman & ceo: redefining women’s health | mad money | cnbc
-
0:58
fda panel recommends aimmune's peanut allergy treatment
-
1:00
nestle buys peanut allergy treatment maker
-
6:19
spark therapeutics ceo: giving sight to the blind | mad money | cnbc
-
6:39
halozyme therapeutics ceo: a step forward | mad money | cnbc
-
5:47
revance therapeutics ceo: challenging allergan | mad money | cnbc
-
5:44
tg therapeutics ceo: finding the right price | mad money | cnbc
-
6:10
intarcia therapeutics ceo: disrupting diabetes | mad money | cnbc